zoledronic acid has been researched along with Nausea in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Shane, E; Walker, MD | 1 |
| Cadarette, SM; Juurlink, DN; Krahn, MD; Lévesque, LE; Mamdani, MM; Tadrous, M; Wong, L | 1 |
| Bensen, W; Chiodo, J; de Villiers, TJ; Mesenbrink, P; Recknor, C; Ryabitseva, O; Wark, JD | 1 |
| Ambler, G; Cowell, CT; Högler, W; Little, D; McQuade, M; Yap, F | 1 |
| Decker, JL; Henderson, C; Hohneker, JA; Kaplan, BH; Lacerna, L; Orlowski, R; Purdy, MH; Schnell, FM; Vogel, CL; Wood, AJ; Yanagihara, RH | 1 |
| Berenson, JR; Conde, F; Henick, K; Nishikubo, C; Rettig, M; Swift, RA; Vescio, R; Von Teichert, JM | 1 |
2 review(s) available for zoledronic acid and Nausea
| Article | Year |
|---|---|
Hypercalcemia: A Review.
Topics: Calcium; Coma; COVID-19; Dehydration; Denosumab; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Immune Checkpoint Inhibitors; Nausea; Neoplasms; Pamidronate; Parathyroid Hormone; SARS-CoV-2; Sleepiness; Sodium Chloride Symporter Inhibitors; Vitamin A; Vitamin D; Vomiting; Zoledronic Acid | 2022 |
Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis.
Topics: Bone Density Conservation Agents; Diphosphonates; Gastrointestinal Diseases; Humans; Imidazoles; Nausea; Osteoporosis; Randomized Controlled Trials as Topic; Zoledronic Acid | 2014 |
3 trial(s) available for zoledronic acid and Nausea
| Article | Year |
|---|---|
Treatment with acetaminophen/paracetamol or ibuprofen alleviates post-dose symptoms related to intravenous infusion with zoledronic acid 5 mg.
Topics: Acetaminophen; Aged; Arthralgia; Body Temperature; Bone Density Conservation Agents; Diphosphonates; Double-Blind Method; Female; Fever; Headache; Humans; Ibuprofen; Imidazoles; Middle Aged; Nausea; Osteoporosis, Postmenopausal; Severity of Illness Index; Treatment Outcome; Zoledronic Acid | 2012 |
Safety and pain palliation of zoledronic acid in patients with breast cancer, prostate cancer, or multiple myeloma who previously received bisphosphonate therapy.
Topics: Aged; Arthralgia; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Creatinine; Diphosphonates; Fatigue; Female; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Multiple Myeloma; Nausea; Pain; Pain Measurement; Prospective Studies; Prostatic Neoplasms; Quality of Life; Treatment Outcome; Zoledronic Acid | 2004 |
A Phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease.
Topics: Adult; Aged; Anorexia; Biomarkers; Bone Neoplasms; Bone Resorption; Constipation; Diphosphonates; Female; Fever; Humans; Imidazoles; Injections, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Pain; Treatment Outcome; Zoledronic Acid | 2001 |
1 other study(ies) available for zoledronic acid and Nausea
| Article | Year |
|---|---|
Short-term safety assessment in the use of intravenous zoledronic acid in children.
Topics: Adolescent; Bone Resorption; Calcium; Child; Child, Preschool; Creatinine; Diphosphonates; Female; Fever; Follow-Up Studies; Humans; Imidazoles; Infusions, Intravenous; Male; Nausea; Pain; Phosphorus; Retrospective Studies; Time Factors; Urea; Vomiting; Zoledronic Acid | 2004 |